Renal Cancer - Results from #2060

Current and future perspectives on functional molecular imaging in nephro-urology: theranostics on the horizon. April 29, 2021

Reoperative Partial Nephrectomy: Does Previous Surgical Footprint Impact Outcomes? April 29, 2021

Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial. April 28, 2021

ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups. April 28, 2021

Pathological characteristics of the large renal mass: potential implication for clinical role of renal biopsy. April 27, 2021

PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer. April 27, 2021

Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis. April 26, 2021

Comparison between minimally-invasive partial and radical nephrectomy for the treatment of clinical T2 renal masses: results of a 10-year study in a tertiary care center. April 26, 2021

Quality of life assessment in renal cell carcinoma Phase II and III clinical trials published between 2010 and 2020: a systematic review. April 23, 2021

Spatial clustering of CD68+ tumor associated macrophages with tumor cells is associated with worse overall survival in metastatic clear cell renal cell carcinoma. April 23, 2021

A Single-arm, Multicenter, Phase 2 Study of Lenvatinib Plus Everolimus in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma. April 22, 2021

Open partial nephrectomy with kidney split: Effective surgical approach to resect completely endophytic tumors. April 22, 2021

Bioinformatic analysis identifying FGF1 gene as a new prognostic indicator in clear cell Renal Cell Carcinoma. April 21, 2021

Stereotactic body radiotherapy for kidney cancer: a 10-year experience from a single institute. April 21, 2021

Diagnostic and prognostic value of ABC transporter family member ABCG1 gene in clear cell renal cell carcinoma. April 20, 2021

Bosniak Classification of Cystic Renal Masses, Version 2019: A Pictorial Guide to Clinical Use. April 20, 2021

TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma. April 20, 2021

Risk Factors and Patterns of Locoregional Recurrence After Radical Nephrectomy for Locally Advanced Renal Cell Carcinoma. April 20, 2021

Clinical Effectiveness of Second-line Sunitinib Following Immuno-oncology Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-world Study. April 19, 2021

Identification and validation of the clinical roles of the VHL-related LncRNAs in clear cell renal cell carcinoma. April 19, 2021

Page 104 of 456